Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review

To investigate progression-free survival (PFS) and event-free survival (EFS) as early efficacy endpoints in diffuse large B-cell lymphoma (DLBCL), this systematic review included phase III randomized controlled trials (RCTs), phase II trials, and retrospective studies in newly diagnosed DLBCL receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jie, Yang, Yong, Tao, Jin, Wang, Shu-Lian, Chen, Bo, Dai, Jian-Rong, Hu, Chen, Qi, Shu-Nan, Li, Ye-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515849/
https://www.ncbi.nlm.nih.gov/pubmed/32651542
http://dx.doi.org/10.1038/s41375-020-0963-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515849/
https://www.ncbi.nlm.nih.gov/pubmed/32651542
http://dx.doi.org/10.1038/s41375-020-0963-1

Ejemplares similares